Absci (ABSI) EBT Margin (QoQ) (2020 - 2026)
Absci (ABSI) EBT Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -918,568.00 |
| Dec 31, 2025 | 299,374.00 |
| Sep 30, 2025 | -243,378.00 |
| Jun 30, 2025 | -289,794.00 |
| Mar 31, 2025 | 212,024.00 |
| Dec 31, 2024 | -274,666.00 |
| Sep 30, 2024 | 34,029.00 |
| Jun 30, 2024 | 49,695.00 |
| Mar 31, 2024 | 450,601.00 |
| Dec 31, 2023 | -400,016.00 |
| Sep 30, 2023 | -171,428.00 |
| Jun 30, 2023 | 60,254.00 |
| Mar 31, 2023 | 405,128.00 |
| Dec 31, 2022 | 166,255.00 |
| Sep 30, 2022 | -466,448.00 |
| Jun 30, 2022 | 502,119.00 |
| Mar 31, 2022 | -913,275.00 |
| Dec 31, 2021 | 1.82 Mn |
| Sep 30, 2021 | -1.06 Mn |
| Jun 30, 2021 | -535,453.00 |